QTTB Q32 Bio Inc.
Price Chart
Executive Summary
Directors OrbiMed Advisors and Xu Diyong each purchased $10M of QTTB common stock at $8/share on May 28, 2026, for a total of $20M (10.1% of market cap). These open-market purchases coincide with a PIPE offering disclosed in the May 27 8-K, indicating insider participation and strong confidence at the offering price.
Key Financial Metrics
Actionable Insight
Insider buying at the PIPE price suggests management views the stock as undervalued. The PIPE provides balance sheet support, reducing near-term financing risk. Monitor for pipeline catalysts (phase updates) that could drive re-rating.
Key Facts
- OrbiMed Advisors LLC and Xu Diyong each bought 1,250,000 shares at $8.00 on 2026-05-28, total $20M.
- Total insider purchase equals ~10.1% of QTTB's $198M market cap.
- Purchases follow a Securities Purchase Agreement (8-K filed 2026-05-27) for a PIPE offering at the same $8 price.
- Both buyers are directors and 10% owners, amplifying the signal.
Financial Impact
Insiders invested $20M at $8/share, representing 10.1% of market cap; PIPE likely raises additional capital from other investors.
Risk Factors
- PIPE dilutes existing shareholders; new shares represent a significant overhang.
- Clinical-stage biotech risk; pipeline failure could impair recovery.
- Low historical win rate on score-6/7 reports for QTTB (calibration suggests caution).
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-QTTB-1780362955879 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
3d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
May 5, 2026
4w ago
|
8-K
| $5.14 $12.64 | ▲ +145.91% | ▲ +140.96% | $13.27 (+158.17%) |
|
Apr 24, 2026
5w ago
|
8-K
| $5.47 $7.09 | ▼ −29.62% | ▼ −24.66% | $13.27 (−142.60%) |
|
Apr 24, 2026
5w ago
|
424B5
| $5.47 $7.09 | ▼ −29.62% | ▼ −24.66% | $13.27 (−142.60%) |
|
Mar 27, 2026
9w ago
|
424B5
| $5.90 $5.72 | ▲ +3.05% | ▲ +15.65% | $13.27 (−124.92%) |
|
Feb 25, 2026
14w ago
|
Insider Cluster
| $4.73 $7.25 | ▲ +53.28% | ▲ +58.51% | $13.27 (+180.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access